Anifrolumab, a relatively new monoclonal antibody, is generating considerable interest within the medical community as a possible solution for various immune-related disorders. This innovative agent targets the immune https://sabrinacukn693905.activoblog.com/51909081/anifrolumab-a-promising-approach-for-autoimmune-conditions